Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

79.74USD
1 Aug 2013
Price Change (% chg)

$1.86 (+2.39%)
Prev Close
$77.88
Open
$79.25
Day's High
$81.75
Day's Low
$79.18
Volume
14,661
Avg. Vol
102,991
52-wk High
$86.29
52-wk Low
$11.19

CLVS.OQ

Chart for CLVS.OQ

About

Clovis Oncology, Inc. is a United States-based biopharmaceutical company. The Company develops anti-cancer agents. It focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets. Its product candidates includes CO-101, a lipid-conjugated form of the... (more)

Overall

Beta: --
Market Cap (Mil.): $2,339.36
Shares Outstanding (Mil.): 30.04
Dividend: --
Yield (%): --

Financials

  CLVS.OQ Industry Sector
P/E (TTM): -- 37.93 37.76
EPS (TTM): -2.73 -- --
ROI: -60.25 19.48 18.76
ROE: -60.46 20.17 19.59
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: ValuEngine, Inc.
$127.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks